Cold atmospheric-pressure plasma is a new technology, widely used in many fields of biomedicine, especially in cancer treatment. Cold plasma can selectively kill a variety of tumor cells, and its biological safety in clinical trials is also very important. In many cases, the patient's immune level is relatively low, so we first studied the safety assessment of plasma treatment in an immunocompromised animal model. In this study, we examined the safety of immuno-deficient nude mice by oral lavage treatment of plasma-activated water, and studied the growth status, main organs and blood biochemical indexes. Acute toxicity test results showed that the maximum dose of plasma treatment for 15 min had no lethal effect and other acute toxicity. There were no significant changes in body weight and survival status of mice after 2 min and 4 min of plasma-activated water (PAW) treatment for 2 weeks. After treatment, the major organs, including heart, liver, spleen, lung and kidney, were not significantly changed in organ coefficient and tissue structure. Blood biochemical markers showed that blood neutrophils and mononuclear cells were slightly increased, and the others remained unchanged. Liver function, renal function, electrolytes, glucose metabolism and lipid metabolism were not affected by different doses of PAW treatment. The above results indicate that PAW treatment can be used to treat immuno-deficient nude mice without significant safety problems.
Introduction
Plasma is an electrically neutral ionizing gas consisting of charged particles (such as electrons, ions), free radicals, molecules and electromagnetism atoms. Cold atmospheric plasma (CAP) is a groundbreaking technique that overcomes the limits of thermal plasma that requires a vacuum chamber and reduces the gas temperature to room temperature so that the cold plasma can be used directly to handle biological tissue [1] . Thus, the application of cold plasma in the medical and biological fields has been developed rapidly in recent years. The most commonly used applications include sterilization, wound healing, dermopathic treatment and cancer treatment [2] [3] [4] [5] [6] [7] . It has been reported that CAP cam efficiently kill various types of tumor cells, including lung cancer, leukemia, intestinal cancer, melanoma, cervical cancer, glioma and pancreatic cancer, etc [8] [9] [10] [11] [12] [13] [14] . Extensive studies have indicated that reactive oxygen/nitrogen species accumulation after plasma treatment play an important role in cancer cell damage, as they are the major intermediates regulating the kinds of cell signaling pathways [15, 16] . For surface treatment such as dermatology, wound healing and skin cancer treatment, CAP could be convenient and well applied [17, 18] . For other tumors that are deep in the body, or hematological tumors such as leukemia and multiple myeloma, plasma-activated liquid such as plasma-activated water (PAW) or plasma-activated medium (PAM) could be applied by precise injection. Water or a medium is pretreated with plasma devices such as a plasma jet or surface plasma for a period of time, then the PAW or PAM contains various reactive species that can be applied in biological applications. Many studies have reported the induction of cell death by PAM in various tumor cells such as glioblastoma brain tumor cells, lung adenocarcinoma cells and ovarian cancer cells [19] [20] [21] [22] [23] . However, before plasma treatment can be applied in clinical trials, the safety of the plasma treatment should be of concern. It has been reported that plasma treatment has a selective effect on prokaryotic cells and eukaryotic cells [24] , meanwhile, plasma treatment selectively induced tumor cells apoptosis but had little cytotoxicity on normal cells [5, 19] . However, few safety studies on plasma treatment on animals instead of on cells have been performed. Furthermore, especially in cancer clinical therapy, for those patients with bone marrow transplant, or for those patients undergoing high-dose chemotherapy, the body's immune system is in a low state, so the body's respond to gas plasma treatment might be different from that when patients are in normal physiological conditions. Therefore, investigation of the safety of PAW treatment of animals in an immuno-deficient condition is important and valuable. In this study, we used BLAB/c nude mice as the animal model that mimicked the immuno-deficient condition.
After two weeks of continuous PAW treatment (different doses), the survival and physiological condition such as body weight, organ coefficient and biochemical indicators were investigated for safety evaluation. An acute toxicity test of the PAW treatment was also performed to check whether the PAW in higher doses had a mortal poisonous effect in the short term.
Experimental arrangement

Dielectric-barrier discharge (DBD) plasma device
In this study, we used a DBD plasma device for plasma generation. A schematic diagram of the device structure is shown in figure 1(a) . The ground electrode is made of a hexagonal steel wire; each mesh element has a closed rim electrode with a hexagon shape, and each side of an element is 4 mm in length, 760 μm in width and 500 μm in thickness. The high-voltage (HV) electrode is a copper plate of 8×6 cm 2 with a sinusoidal power supply. 1 mm thickness polytetrafluroethylene (PTFE) is sandwiched between two electrodes and the surface area is made larger than the ground electrode to avoid flashover discharges. The HV electrode was connected to 10 kHz, and the applied voltage was held at a peak-to-peak value of 5 kV. The electrode unit was housed inside a quartz box of 8×8×6 cm 3 through surrounding air discharge, and the distance between the treated liquid and discharge surface was 1 cm, which can be seen clearly in the DBD photograph in figure 1(b) . The waveforms of the discharge voltage and current were recorded using an oscilloscope (Tektronix, DPO3000), and the discharge voltage and current were measured by a HV probe (Tektronix, P6015A) and a current probe (Tektronix, P6021), respectively. Surface air plasma was sustained with an electrical power of 0.06 W cm −2 .
Optical emission spectroscopy
Emission spectra of the DBD plasma were measured using a UV/visible spectrometer (Maya pro 2000, Ocean Optics, China) within a wavelength range of 200-800 nm. The optical probe was mounted 2 cm away directly facing the discharging area, which guarantees a clear spectrum when detecting the emission spectrum. 
Immuno-deficient mice and plasma treatment
The immuno-deficient mice we chose were BALB/c nude mice, 6-8 weeks old, male, body weight around 20-25 g. The mice were fed in a sterile console, room temperature around 20±3°C, in the animal center of the Medical School, Xi'an Jiaotong University. 24 nude mice were randomly divided into four groups: the control group, PAW 2 min treatment group, PAW 4 min treatment group and the acute toxicity test group. The initial body weight was not significantly different between these four groups. 4 ml of pure water was placed in a 60 mm diameter dish, 1 cm away from the DBD plasma device. The water was treated by DBD plasma at f=10 kHz and V pp =5 kV for 2 min and 4 min, and named PAW 2 min and PAW 4 min. After plasma treatment, 300 μl of PAW was injected immediately into the mouse oral cavity for oral lavage, three times a day for two weeks. During the PAW treatment process, the mice body weight, diet, excretion, mental state and living performance were carefully noted. For the acute toxicity test group, PAW was prepared by treatment of pure water with DBD plasma for 15 min, followed by the same procedure and the symptoms of poisoning and death were recorded over two days.
Evaluation of mouse vital organs
To detect the effect of PAW on mouse organs, the mice were sacrificed by cervical dislocation and dissected after two weeks of PAW treatment. Several vital organs such as the heart, liver, spleen, lung and kidney were separated, weighed and photographed. The appearance and the organ coefficient were noted. The organ coefficient was calculated as organ weight/body weight×100%. Furthermore, small pieces of tissues were taken from the organs of the heart, liver, spleen, lung and kidney. The tissues were fixed with 4% paraformaldehyde, were dehydrated with 30% sucrose, and finally were embedded with OCT compound. The tissues were sectioned using a freezing microtome and the sections were stained by hematoxylineosin (HE) staining. The pathological change after PAW treatment was observed using a microscope (BX53 and DP73, Olympus, Tokyo, Japan).
Biochemical indicator evaluation
Mouse blood was obtained from the mouse eyes using a capillary. Then 0.1 ml of blood was collected in the negative pressure anticoagulant tube for blood routine analysis. An additional 1 ml of blood was collected for clotting in a centrifuge tube for 30 min. Then the samples were centrifuged at 3000 rpm for 10 min and the serum was collected for biochemical indicator detection. All the samples were detected and analyzed by Wuhan Seville Biological Technology Company. The evaluation indicators included blood routine and various biochemical indexes, including liver function, kidney function, electrolytes, glucose and lipid metabolism, etc.
Statistical analysis
The data were processed by statistical software SPSS 17.0. The experimental data were analyzed by mean±sd using the independent sample t-test method. P<0.05 was considered as statistically significant and was marked as * in the tables.
Results
Plasma discharging parameter and characters
The DBD plasma was generated by a sinusoidal power supply at f=10 kHz and V pp =5 kV, with working gas of ambient air. Figure 2 (a) shows the applied voltage curve and the corresponding current during the DBD plasma discharge. The discharge powers were obtained using a V-Q Lissajous figure, as shown in figure 2(b) . To further detail the discharging characteristics of this DBD plasma, a spectrometer was used to measure the emission spectra. As shown in figure 2(c), there were several spectral lines (e.g. OH (A) 309 nm, N 2 (C) 337 nm, + N 2 (B) 391 nm) present in the DBD plasma.
Acute toxicity test by PAW treatment
An acute toxicity test was evaluated by excess PAW treatment. The maximum dose of PAW was prepared by DBD plasma treatment for 15 min of pure water. As shown in table 1, no mice died after the acute toxicity test. The body weight was no different after excess PAW treatment. The mice showed no significant changes in mental state, diet, excretion, sign of poisoning and strange performance. The maximum tolerated dose (MTD) was greater than 15 min/mouse.
Effect of PAW on vital organs
To evaluate the effect of PAW on immuno-deficient mice, several vital organs were monitored. We separated the heart, liver, spleen, lung and kidney. The organ weight and the organ coefficient were measured. As shown in table 2, compared to the control, each organ weight was no different after plasma treatment, either in the PAW 2 min treatment group or in the PAW 4 min treatment group. Similarly, by calculating the organ coefficient, no differences were found after different doses of PAW treatment, indicating that PAW treatment had little effect on the immuno-deficient mice organs.
To further confirm the effect of PAW on vital organs, the heart, liver, spleen, lung and kidney were separated and the tissue sections were obtained. Figure 3 shows the vital organs separated from the immuno-deficient mice that were treated with PAW. All the internal organs of the mice had no abnormality from appearance, and the morphology was complete, regular and smooth. There were no significant differences between the control and the PAW treatment (2 min and 4 min) groups.
Furthermore, frozen sections of these vital organs were prepared and were stained by HE staining for assessing the effect of PAW on the tissue level. As shown in figure 4 , the intramedullary, myocardium and epicardium were intact and the myocardium was composed of regular and arranged cardiac fibers in the treatment group. Liver slices showed that the liver lobular structure was clear, the liver cell cable to the central vein as the center was radially arranged around the interlobular connective tissue visible interlobular vein and monocular. The structure of the spleen was normal, showing the pulp and white pulp and the composition of the pulp structure was intact without thickening, lymphocyte differentiation was good, and the middle of the spleen could be seen in the central artery. Lung slices could be seen in the alveolar structure arranged in close order, the alveolar septum was clear, with no alveolar enlargement and fusion, and there was no bronchial wall fibrous thickening or inflammatory response. The renal structure was clear and complete, with endothelial cells and mesangial cells around the renal tubular, cortical area could be seen with a glomerular structure. On the whole, there were no obvious abnormal changes in the organs in the PAW treatment group compared to the control, indicating that PAW treatment did not affect mice organ function.
Effect of PAW on blood biochemical index
To investigate whether PAW treatment had a effect on the blood biochemical index of the immuno-deficient mice, we detected the blood routine and various biochemical indexes including liver function, kidney function, electrolytes, glucose and lipid metabolism, etc. Table 3 shows the blood routine test before and after PAW (2 min and 4 min) treatment for two weeks. Most of the indicators were not affected by PAW treatment, however, it is noteworthy that some immune cells (monocytes and neutrophils) were increased after PAW treatment, which means that the PAW treatment may somehow activate the immune cells in the immuno-deficient mice. Next, we investigated the blood biochemical index of the liver function after PAW treatment in immuno-deficient mice. As shown in table 4, no differences were found in liver function after PAW (2 min and 4 min) treatment in mice, indicating that the PAW treatment did not induce liver damage in the immuno-deficient mice.
Kidney function and electrolytes were also detected after PAW treatment. The results showed that PAW treatment in immuno-deficient mice had no significant effect on mouse kidney function and electrolyte level (table 5), indicating that PAW treatment was safe for the water electrolyte balance.
In addition, the level of glucose and lipid were also detected after PAW treatment in mice. Table 6 shows the results of blood glucose and several kinds of lipid in serum; PAW treatment did not affect the glucose and lipid metabolism in immuno-deficient mice as no significant differences were found in the analysis.
Discussion
Atmospheric-pressure-cooled plasma has been a new research field in recent years, and it has aroused widespread concern in many fields, especially in biomedical applications, because of its atmospheric pressure, low gas temperature and high particle activity. At present, the structural design, the introduction of gas and the parameter adjustment of the CAP generating devices are different among each research team. In addition, there is no unified and normalized management standard for setting the work parameters and assessing the security of the CAP device. Thus, it is essential to carry out the safety evaluation of the CAP device, according to the specific experimental subject and purpose in biomedical research [25, 26] . The main discharge mode of cold plasma is DBD at the moment, which has mostly been applied in plasma jets and surface air plasma [12, 27, 28] . In this study, we used surface air plasma to treat water and prepare the PAW. The characteristics of the plasma generation and electronic parameters were well illustrated in our previous works [29, 30] . We also demonstrated that plasma could 3 3 in PAW, the concentration of several major long-lived species were measured and analyzed [28] [29] [30] . From the previous data we knew that PAW 2 min or 4 min treatment could efficiently reduce the bacteria viability [30] or cause Hacat cell apoptosis [28] . Therefore, we mostly focused on the safety of application of PAW in vivo.
We used BALB/c nude mice in this study to represent an immune deficiency state. As we know, in clinical trials there are a lot of patients that are in poor immune status due to high doses of chemotherapy and consumptive disease. In this study, oral lavage was chosen for PAW treatment because oral ulcers are one of the common complications in patients with malignant tumors after chemotherapy, and they bring great pain to patients, affecting their eating and even hindering further therapy [31] . If the therapy of leukemia or other blood diseases is considered in a later study, intravenous injection will be a suitable way. Our results showed that the PAW treatment with acute MTD was more than 15 min/mouse, indicating that PAW has little acute toxicity. The reason for choosing 15 min for the acute toxicity test is that it is about the limitation of our plasma device, the temperature of which rises with increasing treatment time. If the processing time was set to more than 15 min, the excessive temperature might break the plasma device, affecting the stability and precision of our results. After The results also manifested that most blood routine and biochemical indexes in the PAW treated mice were not significantly changed compared with the control group, except the number of mononuclear cells, the percentage of monocytes and neutrophils, which were slightly higher than those of the control group, reflecting that PAW might activate the immune response of partly immuno-deficient mice (nude mice). Zhong et al [28] reported that surface air plasma elevated the expression of IL-1β, IL-6, IL-6, IL-8, TNF-α, interferon-γ and VEGF but reduced the level of IL-12, suggesting that CAP treatment could influence the immune response of human keratinocytes. There have only been a few studies on the immune mechanism activated by gas plasma so far. Lena et al [32] reported that argon plasma jet could impact human immune cell lines through a MAPK signaling pathway. However, which immune signaling pathway involved in the surface air plasma has not been reported yet, thus it is necessary and valuable to study this in future work. According to the results of this study, we demonstrated that PAW treatment was not toxic to the BALB/c nude mice. It appears that the first study on the safety of PAW to immune deficiency mice provides good evidence for the further application of PAW in clinical medicine, especially in those that are in poor immune status.
Conclusions
In conclusion, we presented a first report on the safety of PAW treatment to immune deficiency mice. Oral lavage of PAW treatment on nude mice has no lethal effect and other acute toxicity.
There is no significant change in organ coefficient and tissue structures in the major organs. Liver function, renal function, electrolytes, glucose metabolism and lipid metabolism are not affected by different doses of PAW treatment. Our results indicate that PAW treatment can be used to treat immunodeficient nude mice without significant safety problems.
